Google, OrbiMed buy into Alector’s novel take on Alzheimer’s with a $32M round – FierceBiotech

Under-the-radar biotech startup Alector raised $32 million in Series C funds to support its early-stage work in neurodegenerative disease, recruiting some high-profile investors as it develops a novel approach to brain-destroying disorders.

Source: www.fiercebiotech.com

---